A Phase 2/3 interventional study of Yogurt supplemented with L. rhamnosus fiti and Yogurt not supplemented with a probiotic strain. in Bacterial Vaginosis, sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's. Completed at 1 site in Tanzania. Open to female participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2010-12-13.
Sponsored by London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's · Phase 2/3, Interventional, and Treatment
Purpose of the proposed research is to determine the impact of probiotic yogurt supplemented with Lactobacillus rhamnosus (Fiti) compared to regular yogurt on the well-being of women living with HIV.
220 studies on the registry are indexed under Vaginosis, Bacterial; 36 are open to participants now.
This study's planned enrollment of 150 is above the median of 100 across 187 interventional studies indexed under Vaginosis, Bacterial.
Browse Vaginosis, Bacterial studies →London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's is the lead sponsor of 352 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Dietary Supplement: Yogurt supplemented with L. rhamnosus fiti
Dietary Supplement: Yogurt not supplemented with a probiotic strain.
200 ml of L. rhamnosus fiti at 10\*9 cfu/ml daily for 30 days.
200 ml yoghurt without L. rhamnosus fiti daily for 30 days.
Vaginal microbiota of HIV patients.
Time frame: 30 days
Bacterial vaginosis.
Time frame: 30 days
This study is completed, as verified in Dec 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's